A list of commonly used measurement tools for psoriasis management and clinical trials.
CDLQI: tHE CHILDREN'S DERMATOLOGY LIFE QUALITY INDEX: MEASURING THE IMPACT OF SKIN DISEASE ON THE LIVES OF CHILDREN
A 10-question questionnaire based on the experiences of children with skin disease. Available in both a text-only version as well as The Cartoon CDLQI, with each question illustrated by a cartoon based on the theme of the question, catering to younger children.
Link and free download available
DLQI: DERMATOLOGY QUALITY OF LIFE INDEX: Measuring disease severity and quality of life
A simple 10-question validated questionnaire that has been used in over 40 different skin conditions in over 80 countries and is available in over 90 languages to measure disease severity and quality of life.
To express the severity of psoriasis by measuring redness, thickness, and scaliness of the lesions, weighed by the area of involvement.
Physician's assessment of the severity of disease based on a scale from clear to very severe.
PEST: Psoriasis Epidemiology Screening Tool
PEST is a validated screening tool for psoriatic arthritis (PsA) and it is recommended that patients with psoriasis who do not have a diagnosis of PsA complete an annual PEST questionnaire (NICE psoriasis guidelines 2012). A score of 3 or more indicates referral to rheumatology should be considered.
HELP US ENHANCE OUR LIST OF AVAILABLE TREATMENT GUIDELINES. SEND INFORMATION AND LINKS TO INFO@PSORIASISCOUNCIL.ORG
congress coverage AAD 2019 Annual Meeting Read the psoriasis highlights from the congress learn more
Psoriasis News Announcing IPC's Newest Corporate Partner: Ortho Dermatologics9/3/2019 11:11:00 AM Get Connected: World Psoriasis Day 20199/3/2019 9:41:00 AM In Memory of Gladys León Dorantes9/2/2019 3:24:00 PM Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council8/29/2019 7:13:00 AMPsoriasis severity categories have been important tools for clinicians to use in treatment decisions as well as to determine eligibility criteria for clinical studies. However, due to the heterogeneity of severity classifications and their lack of consideration for the impact of psoriasis involvement of special areas or past treatment history, patients may be mis-categorized, which can lead to under-treatment of psoriasis. More News